Isoamylase-producing recombinant bacterium as well as construction method and application thereof

By knocking out specific genes in Bacillus subtilis and using signal peptides to mediate the expression of isoamylase, the safety and efficiency problems in the industrial production and application of isoamylase are solved, and the production of high-efficiency and high-performance isoamylase is achieved, which is significantly Improves enzyme activity and expression efficiency.

CN118909903APending Publication Date: 2024-11-08JIANGSU OGO BIOTECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411330790.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The industrial production and application of isoamylases in the prior art have not yet met expectations, especially in terms of safety and efficiency, and hosts such as E. coli and Pichia cerevisiae have food safety problems and low production efficiency.

Method used

A genetic modification strategy for the use of Bacillus subtilis as a host to optimize the isoamylase encoding gene and signal peptide by knocking out the amyE, amyL, srfC and spoIIAC genes and using signal peptides to mediate the secretion and expression of exogenous isoamylases. , to increase the yield and enzyme activity of isoamylase.

Benefits of technology

It has achieved efficient production of high-performance isoamylase in Bacillus subtilis, and the extracellular enzyme activity of shake flask fermentation reaches 24.3U·mL-1 or above, significantly improving the expression and secretion efficiency of isoamylase and laying the foundation for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909903A_ABST
    Figure CN118909903A_ABST
Patent Text Reader

Abstract

The invention relates to a recombinant bacterium for producing isoamylase as well as a construction method and application of the recombinant bacterium. A brand new genetic modification strategy is designed on the basis of bacillus subtilis, amyE, amyL, srfC and spoIIAC genes are knocked out in the bacillus subtilis, meanwhile, signal peptide is utilized for mediating secretory expression of exogenous isoamylase, and efficient production of the isoamylase through the bacillus subtilis is achieved; besides, by optimizing the coding gene of the isoamylase and designing a specific signal peptide, the expression of the isoamylase can be further improved, the extracellular enzyme activity of shake flask fermentation culture can reach 24.3 U.mL <-1 > or above, and a foundation is laid for amplified production of the isoamylase.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering and relates to an isoamylase-producing recombinant bacterium and a construction method and application thereof. Background Art

[0002] Isoamylase (EC 3.2.1.68) is a type of starch debranching enzyme. It can hydrolyze α-1,6 glycosidic bonds in glycogen, amylopectin and β-limit dextrin, and has a partial hydrolysis effect on α-limit dextrin, but cannot hydrolyze pullulan. Isoamylase has important application value in the starch processing industry. It can be compounded with amylases such as saccharifying enzymes, β-amylases, CGTases, 4-α-glucan transferases, etc. to produce glucose, maltose, cyclodextrin, resistant starch and other products, shorten the reaction time, improve the conversion rate of starch, and reduce the use of other saccharification enzyme preparations, thereby achieving the purpose of increasing production, improving equipment utilization, and reducing production costs. Although the application range of isoamylase in industry is becoming wider and wider, so far only the isoamylase mainly derived from Pseudomonas amyloderamosa has achieved industrial production.

[0003] As an important isoamylase market in the world, China has seen an upward trend in both supply and demand in the industry in recent years. Research on isoamylase mainly focuses on strain screening, mutagenesis, enzyme separation and purification, and enzymatic characterization. For example, a study reported that the isoamylase encoding gene was cloned by PCR using T.fusca genomic DNA as a template, and recombinant isoamylase-producing Escherichia coli was constructed. The shake flask fermentation conditions for recombinant isoamylase were optimized, and the intracellular enzyme activity level of the recombinant bacteria reached 879.2U / mL after 36h of shake flask fermentation.

[0004] At present, there are many research reports on the expression of isoamylase in Escherichia coli and Pichia pastoris, but Escherichia coli is not a microorganism that is considered safe in principle, and Pichia pastoris also has the problem of food safety induced by methanol and the problem of long fermentation time. Although there are rare reports in Bacillus licheniformis, which is also a food safety grade strain, Bacillus licheniformis has not been put into actual production and application to produce isoamylase. Bacillus subtilis is a Gram-positive bacterium with the characteristics of non-pathogenicity, non-endotoxin production and pyrogenic protein. As a food-grade safety strain, it has been used for a long time to prepare fermented foods, such as CN112980755A discloses a genetically engineered bacterium that efficiently secretes isoamylase, and the genetically engineered bacterium uses Bacillus subtilis as a host, knocks out the coding gene of α-amylase and secretes and expresses isoamylase, wherein the glycoside hydrolase family 5 endoglucanase derived from Bacillus subtilis is fused to the N-terminus of isoamylase, and promotes the secretion of isoamylase as an enhancer, and the isoamylase is a natural isoamylase or a mutant thereof derived from Sulfolobus sulphurans.

[0005] In summary, there have been reports on engineered bacteria that produce isoamylase, but there is still a certain distance from industrial production and application. Therefore, the development of technical means to effectively increase the production of isoamylase and produce high-performance isoamylase is of great significance to promote the application of isoamylase. Summary of the invention

[0006] In view of the deficiencies in the prior art and actual needs, the present invention provides a recombinant bacterium producing isoamylase and a construction method and application thereof, in order to achieve efficient production of high-performance isoamylase.

[0007] To achieve this object, the present invention adopts the following technical solutions:

[0008] In a first aspect, the present invention provides a recombinant bacterium producing isoamylase, wherein the recombinant bacterium uses Bacillus subtilis as a host and expresses isoamylase, wherein the isoamylase is also fused with a signal peptide, and the recombinant bacterium also lacks amyE, amyL, srfC and spoIIAC genes.

[0009] The present invention designs a new genetic modification strategy, knocks out amyE, amyL, srfC and spoIIAC genes in Bacillus subtilis, and simultaneously utilizes signal peptide-mediated secretory expression of exogenous isoamylase to achieve efficient production of isoamylase in Bacillus subtilis.

[0010] Preferably, the nucleic acid sequence of the gene encoding the isoamylase includes the sequence shown in SEQ ID NO.1.

[0011] Preferably, the recombinant bacterium also lacks at least one of the NprE, AprE, NprB, Epr, Bpr, Vpr, Mpr or WprA genes.

[0012] In the present invention, a specific gene knockout strategy is designed to further increase the yield of isoamylase.

[0013] In the present invention, the gene encoding isoamylase is optimized and designed, which can further improve the expression of isoamylase.

[0014] Preferably, the signal peptide comprises at least one of a sacBss signal peptide, a ywtF signal peptide or a phrK signal peptide.

[0015] In the present invention, a specific signal peptide is designed and used to further improve the enzymatic activity of secreted and expressed isoamylase.

[0016] Preferably, the nucleic acid sequence of the gene encoding the sacBss signal peptide includes the sequence shown in SEQ ID NO.3.

[0017] Preferably, the nucleic acid sequence of the gene encoding the ywtF signal peptide includes the sequence shown in SEQ ID NO.4.

[0018] Preferably, the nucleic acid sequence of the gene encoding the phrK signal peptide includes the sequence shown in SEQ ID NO.5.

[0019] SEQ ID NO.3:

[0020] atgaacatcaaaaagtttgcaaaacaagcaacagtattaacctttacctaccgcactgctggcaggaggcgcaactc aagcgtttgcgcatcatcatcatcat.

[0021] SEQ ID NO.4:

[0022] atggaagaacgatcacagcgcagaaagaaaaaaagaaaactaaaaaaatgggtgaaagttgttgccggattaatg gcttttttagtcattgcggcaggctctgtcggcgcctatgct.

[0023] SEQ ID NO.5:

[0024] atgaaaaaacttgtgctttgcgtatctattttagctgtgattttaagtggagtagctttaacgcaattgagtacagattcac catctaacatccaggtagctgaaaggccagtcggaggttaa.

[0025] It can be understood that the present invention designs a genetic modification strategy for Bacillus subtilis, and any common Bacillus subtilis in the art is theoretically applicable to the present invention.

[0026] Preferably, the Bacillus subtilis includes Bacillus subtilis ATCC 6051a.

[0027] In a second aspect, the present invention provides a recombinant plasmid for expressing isoamylase in the isoamylase-producing recombinant bacteria described in the first aspect, wherein the recombinant plasmid contains a promoter, a signal peptide coding sequence, an isoamylase coding gene and a termination sequence, wherein the signal peptide coding sequence and the isoamylase coding gene are fused in an open reading frame and are operably connected to the promoter sequence.

[0028] Preferably, the starting plasmid of the recombinant plasmid includes pHY300-PLK plasmid.

[0029] Preferably, the promoter comprises a xylose isomerase promoter.

[0030] Preferably, the nucleic acid sequence of the xylose isomerase promoter includes the sequence shown in SEQ ID NO.6.

[0031] SEQ ID NO.6:

[0032]

[0033] In a third aspect, the present invention provides a method for constructing the isoamylase-producing recombinant bacteria according to the first aspect, the construction method comprising:

[0034] Bacillus subtilis is used as a host, the amyE, amyL, srfC and spoIIAC genes are knocked out, and the recombinant plasmid described in the second aspect is introduced to obtain an isoamylase-producing recombinant bacterium.

[0035] Preferably, at least one of the NprE, AprE, NprB, Epr, Bpr, Vpr, Mpr or WprA genes is also knocked out.

[0036] It is understood that the methods of gene knockout, vector construction and transduction commonly used in the art are all applicable to the present invention as long as they can implement the genetic modification strategy of the present invention.

[0037] In a fourth aspect, the present invention provides use of the isoamylase-producing recombinant bacteria described in the first aspect in producing isoamylase.

[0038] In the present invention, an isoamylase-producing recombinant bacterium is designed and constructed to achieve efficient production of thermostable isoamylase, which has broad application prospects, such as being used in the production of β-cyclodextrin, etc., to improve related production conversion rates and reduce production costs.

[0039] In a fifth aspect, the present invention provides a method for producing isoamylase, the method comprising:

[0040] The isoamylase-producing recombinant bacteria described in the first aspect are fermented and cultured, and the product is purified to obtain isoamylase.

[0041] It is to be understood that the cultivation methods for strains suitable for secreting isoamylase and the product purification methods commonly used in the art are applicable to the present invention.

[0042] Compared with the prior art, the present invention has the following beneficial effects:

[0043] The invention is based on Bacillus subtilis and designs a new genetic modification strategy. The amyE, amyL, srfC and spoIIAC genes are knocked out in Bacillus subtilis, and the secretion and expression of exogenous isoamylase are mediated by a signal peptide, so as to realize the efficient production of isoamylase in Bacillus subtilis. In addition, the expression of isoamylase can be further improved by optimizing the isoamylase encoding gene and designing a specific signal peptide, and the extracellular enzyme activity of shake flask fermentation culture can reach 24.3 U·mL -1 Above, such as 56.2 U·mL -1 , which laid the foundation for the large-scale production of isoamylase. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] Figure 1Schematic diagram of the structure of the recombinant plasmid pBSIA;

[0045] Figure 2 This is the SDS-PAGE electrophoresis of the extracellular supernatant of the recombinant bacteria WS3IA~WS11IA fermentation. DETAILED DESCRIPTION

[0046] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following examples are only simplified examples of the present invention and do not represent or limit the scope of protection of the present invention. The scope of protection of the present invention shall be subject to the claims.

[0047] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0048] In view of the current demand for efficient production of high-performance isoamylase, the present invention designs a genetic modification strategy to achieve efficient production of high-performance isoamylase in Bacillus subtilis.

[0049] Example 1

[0050] This example constructs a recombinant bacterium that produces isoamylase.

[0051] (1) Optimization of isoamylase gene sequence

[0052] The thermostable isoamylase gene (isoamylase, 2151 bp) from the hyperthermophilic archaeon Sulfolobus tokodaii was codon optimized and modified throughout the sequence to adjust its GC content and mRNA stability. The optimized sequence is shown in SEQ ID NO.1 and was then handed over to Shanghai Sangon Biotechnology Co., Ltd. for gene sequence synthesis.

[0053] SEQ ID NO.1:

[0054]

[0055] (2) Construction of expression vector

[0056] Firstly, the recombinant plasmid pBSSY2 constructed in the laboratory was used as a template, and PxylF and PxylsR were used as primers to amplify the gene fragment Blxyl-sacBss (SEQ ID NO.2) containing the promoter of xylose isomerase and its regulatory protein gene and signal peptide. The reaction conditions were: 95℃, 10min, 95℃, 30s, 54℃, 30s, 72℃, 2min, 30 cycles, 72℃10min. Then, the pHY300-PLK plasmid was digested with HindⅢ and KpnⅠ, and then cloned into the plasmid pHY300-PLK through gel recovery to obtain the recombinant plasmid pBSxys for xylose-induced secretory expression, which was then transformed into E.coli DH5α, namely E.coli DH5α / pBSxys. Then, pET28a-IA-ter was used as a template, and the primers PxylsF and PterR were used to amplify the thermostable isoamylase structural gene (SEQ ID NO.1). The reaction conditions were the same as above. After digestion with KpnⅠ and XbaⅠ, the gene was recovered by gel and cloned into pBSxys, which was the recombinant plasmid pBSIA that induced xylose to secrete and express thermostable isoamylase. After transformant screening, the gene was sent for sequencing. After the sequencing was correct, E. coli DH5α / pBSIA carrying the pBSIA recombinant plasmid was obtained. The plasmid size was about 8.57 kp. The schematic diagram of the structure of the recombinant plasmid pBSIA is shown in Figure 1 , Blxyl-xylose isomerase promoter and its regulatory protein gene; sacBss-Bacillus subtilis fructan synthase signal peptide gene; IA-hyperthermophilic archaeon Sulfolobus tokodaii high temperature resistant isoamylase gene; ter-terminator of xylose isomerase gene.

[0057] Table 1

[0058]

[0059]

[0060] a The underlined sequences are restriction enzyme cleavage sites.

[0061] SEQ ID NO.2:

[0062]

[0063] (3) Construction of recombinant bacteria

[0064] E. coli DH5α / pBSxys and E. coli DH5α / pBSIA were cultured, and the recombinant plasmids pBSxys and pBSIA were extracted and transferred into WSB3, WSB4, ..., WSB10, and WSB11 hosts (Bacillus subtilis ATCC 6051a respectively knocked out protease and amylase genes, foam genes, and spore genes to varying degrees. Specifically, WSB3 knocked out two amylase genes: amyE and amyL, one foam gene: srfC, and one spore formation gene: spoIIAC; WSB4 knocked out NprE based on WSB3; WSB5 knocked out AprE based on WSB4, and WSB6 knocked out NprB based on WSB5; WSB7 knocked out Epr based on WSB6; WSB8 knocked out Bpr based on WSB7; WSB9 knocked out Vpr based on WSB8; WSB10 knocked out Mpr based on WSB9; and WSB11 knocked out WprA based on WSB10), thereby obtaining recombinant B. subtilis WSB3IA~WSB11IA.

[0065] (4) Shake flask fermentation and SDS-PAGE analysis of recombinant bacteria

[0066] Take 20 μL of glycerol tube bacteria B. subtilis WS3IA~WS11IA and inoculate it into 10 mL LB liquid culture medium (containing 10 μg / mL tetracycline), and place it in a constant temperature shaker at 37°C and 200 rpm for 9 hours. Then, take 2.5 mL of the cultured bacterial solution and transfer it to 50 mL TB liquid culture medium (containing 20 μg / mL tetracycline), and place it in a constant temperature shaker at 37°C and 200 rpm for 48 hours. When the fermentation reaches 12 hours, add 10 g / L of xylose to the fermentation broth to start the expression of the isoamylase gene. After the fermentation is completed, centrifuge at 10000 rpm for 10 minutes to collect the supernatant, which is the crude enzyme solution. The crude enzyme solution is taken for SDS-PAGE analysis. The results are as follows Figure 2As shown, M: medium molecular weight protein Marker, lane 1: WS3IA, lane 2: WS4IA, lane 3: WS5IA; lane 4: WS6IA, lane 5: WS7IA, lane 6: WS8IA, lane 7: WS9IA; lane 8: WS10IA, lane 9: WS11IA, different recombinant bacteria all expressed a clear band of about 81 kDa, and the expression levels of different recombinant bacteria B. subtilis WS3IA~WS11IA were different, which was consistent with the expected results of the recombinant protein, indicating that the heterologous isoamylase gene was expressed in Bacillus subtilis, and also that different proteases had different effects on the recombinant protein.

[0067] Method for detecting the activity of crude enzyme solution of high-temperature isoamylase: prepare 0.5% (w / v) amylopectin with pure water, boil for 5 minutes after slight boiling, cool and fix the volume. Prepare 0.2mol / L sodium acetate buffer containing 2.5mmol / L MgCl2. Then take 350μL of the prepared amylopectin and add 100μL buffer, then add 50μL of crude enzyme solution diluted to a certain multiple, and react in a 90℃ water bath for 30min. After the reaction is completed, take 0.5mL of 0.01mol / L iodine solution and 0.1mol / L KI mixed solution, then add 9mL water, leave at room temperature for 10min, and measure the absorbance at 610nm. The absorbance value that increases by 0.01 equivalents per minute is defined as 1 enzyme activity unit. The enzyme activity calculation formula is: E = (ΔA×100) / (30×0.05)×n, where ΔA represents the absorbance difference, that is, the absolute value of the difference between the sample absorbance value and the blank absorbance value. ΔA is preferably in the range of 0.4 to 0.7, and n is the dilution multiple.

[0068] The extracellular enzyme activity and the bacterial concentration detected by the shaking flask are shown in Table 2. The results show that the present invention successfully constructs a recombinant Bacillus subtilis that produces thermostable isoamylase, and the recombinant bacteria WS9IA has the highest extracellular enzyme activity, which is 52.6 U·mL -1 , is the recombinant WS3IA enzyme activity (24.3U·mL -1 ), and the growth of the recombinant bacteria was also the best.

[0069] Table 2

[0070]

[0071] Example 2

[0072] This example constructs an isoamylase-producing recombinant bacterium, including using different signal peptides to express isoamylase.

[0073] First, a signal peptide screening library was established using the kit B.subtilis Secretory Protein Expression System, and then the established signal peptide library was tested using a high-throughput screening method. According to the property that isoamylase can hydrolyze starch, 1% soluble starch was added to the LB solid culture medium, and then a strain with a larger transparent circle than the control strain was selected for 96-well plate rescreening. Finally, the strain with a larger transparent circle in the rescreening result was selected for triangular flask culture rescreening, and the signal peptide of the strain with higher enzyme activity was sequenced. Through the above screening, two better signal peptides were obtained, namely the ywtF gene signal peptide and the phrK gene signal peptide, both of which belong to the Sec secretory pathway signal peptide. The sacBss gene signal peptide in the isoamylase expression plasmid pBSIA was replaced with the ywtF gene signal peptide (SEQID NO.4) and the phrK gene signal peptide (SEQ ID NO.5) to obtain the expression plasmids pBSIA / ywtF and pBSIA / phrK, which were then electrotransferred to the WS9 host. Through expression in shake flasks, it was found that the balance relationship was relatively better under the mediation of the ywtF gene signal peptide, resulting in a relatively higher extracellular enzyme activity (as shown in Table 3).

[0074] Table 3

[0075] WS9 / pBSIA / ywtF WS9 / pBSIA / ywtF <![CDATA[OD 600 ]]> 49.3 48.4 Enzyme activity (U / mL) 56.2 52.3

[0076] In summary, the present invention designs a new genetic modification strategy, optimizes the isoamylase gene from Sulfolobus tokodaii, constructs a recombinant expression vector induced by xylose and mediated by signal peptide for secretory expression, establishes a signal peptide library and screens it, and verifies it at the shake flask level, thereby obtaining a recombinant Bacillus subtilis strain that can achieve the expected level of isoamylase production, laying the foundation for the subsequent large-scale production of thermostable isoamylase.

[0077] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.

Claims

1. A recombinant bacterium producing isoamylase, characterized in that: The recombinant bacteria uses Bacillus subtilis as a host, expresses isoamylase, the isoamylase is also fused with a signal peptide, and the recombinant bacteria lacks amyE, amyL, srfC and spoIIAC genes.

2. The isoamylase-producing recombinant bacterium according to claim 1, characterized in that: The nucleic acid sequence of the gene encoding the isoamylase includes the sequence shown in SEQ ID NO.1; Preferably, the recombinant bacterium also lacks at least one of the NprE, AprE, NprB, Epr, Bpr, Vpr, Mpr or WprA genes.

3. The isoamylase-producing recombinant bacterium according to claim 1 or 2, characterized in that: The signal peptide includes at least one of a sacBss signal peptide, a ywtF signal peptide or a phrK signal peptide.

4. The isoamylase-producing recombinant bacterium according to any one of claims 1 to 3, characterized in that: The Bacillus subtilis includes Bacillus subtilis ATCC 6051a.

5. A recombinant plasmid for expressing isoamylase in the isoamylase-producing recombinant bacterium according to any one of claims 1 to 4, characterized in that: The recombinant plasmid contains a promoter, a signal peptide coding sequence, an isoamylase coding gene and a termination sequence, wherein the signal peptide coding sequence and the isoamylase coding gene are fused in an open reading frame and are operably connected to the promoter sequence.

6. The recombinant plasmid according to claim 5, characterized in that The starting plasmid of the recombinant plasmid includes pHY300-PLK plasmid.

7. The recombinant plasmid according to claim 5 or 6, characterized in that The promoter includes the xylose isomerase promoter.

8. A method for constructing a recombinant bacterium producing isoamylase according to any one of claims 1 to 4, characterized in that: The construction method comprises: Bacillus subtilis is used as a host, amyE, amyL, srfC and spoIIAC genes are knocked out, and the recombinant plasmid described in any one of claims 5 to 7 is introduced to obtain a recombinant bacterium producing isoamylase.

9. Use of the isoamylase-producing recombinant bacteria according to any one of claims 1 to 4 in producing isoamylase.

10. A method for producing isoamylase, characterized in that: The method comprises: Fermentation and cultivation of the isoamylase-producing recombinant bacteria according to any one of claims 1 to 4, and purification of the product to obtain isoamylase.

Citation Information

Cited By

  • Recombinant bacillus subtilis and application thereof

    CN121699826A